ask="1.0000"
ask_size="1700"
average_daily_volume="1144950"
bid="0.9441"
bid_size="1100"
book_value="0.6060"
change="+0.0248"
change_from_200_day_moving_average="-1.9540"
change_from_50_day_moving_average="0.0342"
change_from_52_week_high="-3.9651"
change_From_52_week_low="0.4648"
change_in_percent="+2.6383%"
close="0.9648"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="0.1900"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.0300"
high_52_weeks="4.9299"
last_trade_date="1/4/2017"
last_trade_price="0.9648"
last_trade_size="5000"
last_trade_time="3:57pm"
low="0.9200"
low_52_weeks="0.5000"
market_capitalization="6.89M"
moving_average_200_day="2.9188"
moving_average_50_day="0.9306"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-66.9457%"
percent_change_from_50_day_moving_average="+3.6744%"
percent_change_from_52_week_high="-80.4296%"
percent_change_from_52_week_low="+92.9600%"
previous_close="0.9400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.0779"
price_per_book="1.5512"
price_per_sales="2.6259"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.2200"
stock_exchange="NCM"
symbol="OPXA"
volume="262101"
weeks_range_52="0.5000 - 4.9299"
